imperatorin has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, B; Yang, Y; You, C | 1 |
| Chanvorachote, P; Choochuay, K; Chunhacha, P; Luechapudiporn, R; Pongrakhananon, V | 1 |
2 other study(ies) available for imperatorin and Lung Neoplasms
| Article | Year |
|---|---|
Imperatorin Targets MCL-1 to Sensitize CD133+ Lung Cancer Cells to γδ-T Cell-Mediated Cytotoxicity.
Topics: A549 Cells; AC133 Antigen; Animals; Antibodies, Neutralizing; Apoptosis; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Furocoumarins; Humans; Intraepithelial Lymphocytes; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2018 |
Imperatorin sensitizes anoikis and inhibits anchorage-independent growth of lung cancer cells.
Topics: Anoikis; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Furocoumarins; Humans; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Metastasis; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Suppressor Protein p53 | 2013 |